Genesis Healthcare, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2017. For the quarter, the company reported net revenue of $1,389,132,000 against $1,472,218,000 a year ago. Loss before income tax expense was $82,308,000 against $67,926,000 a year ago. Loss from continuing operations was $83,592,000 against $70,990,000 a year ago. Net loss was $83,613,000 against $71,028,000 a year ago. Net loss attributable to company was $50,761,000 or $0.55 per share against $43,039,000 or $0.48 per share a year ago. Net cash provided by operating activities was $44,630,000 against $24,446,000 a year ago. EBITDA was $106,815,000 against $129,020,000 a year ago. Adjusted EBITDAR was $165,690,000 against $178,351,000 a year ago. Adjusted EBITDA was $129,590,000 against $141,035,000 a year ago.

For the year 2017, the company expects revenue of range from $5,400.0 million to $5,500.0 million. Net loss attributable to company of range between $159.0 million to $148.0 million. EBITDA of $503.0 million to $535.0 million. Adjusted EBITDA of range between $542.0 million to $573.0 million. Adjusted EBITDAR of range between $675.0 million to $710.0 million.